Pacritinib
Back to searchMolecule Structure
Scientific Name
Pacritinib
Description of the Drug
Pacritinib is a kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11697
http://www.drugbank.ca/drugs/DB11697
Brand Name(s)
Not Available
Company Owner(s)
Cti Biopharma Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tyrosine-protein kinase receptor FLT3 | SINGLE PROTEIN | INHIBITOR | CHEMBL1974 |
| Tyrosine-protein kinase JAK2 | SINGLE PROTEIN | INHIBITOR | CHEMBL2971 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1108221 |
| DrugBank | DB11697 |
| PubChem: Thomson Pharma | 104174247 |
| PubChem | 46216796 |
| PDBe | 6T3 |
| BindingDB | 50210177 |
| Brenda | 27071 |
| ChemicalBook | CB82628224 |
| Guide to Pharmacology | 7793 |
| ZINC | ZINC000043153645 |
